BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS










 Company News
Agios Pharmaceuticals (AGIO) Announces Proposed Offering Of Common Stock 4/22/2014 7:56:35 AM    More...
Agios Pharmaceuticals (AGIO) Initiates Phase 1 Study Of AG-348, A First-in-class PKR Activator, For Pyruvate Kinase Deficiency 4/17/2014 9:30:24 AM    More...
Whoa. Agios Pharmaceuticals (AGIO)'s Experimental Cancer Drug Makes Cancer Undetectable In Three Patients 4/7/2014 7:31:23 AM    More...
Agios Pharmaceuticals Announces Clinical And Preclinical Data To Be Presented At American Association for Cancer Research Annual Meeting 2014 3/31/2014 6:40:27 AM    More...
Agios Pharmaceuticals Enrolls First Patient In Phase 1 Study Of AG-120 In Advanced Solid Tumors With An IDH1 Mutation 3/24/2014 9:35:14 AM    More...
Agios Pharmaceuticals Announces Enrollment Of First Patient In Phase 1 Study Of AG-120 In Advanced Hematologic Malignancies With An IDH1 Mutation 3/19/2014 9:20:15 AM    More...
Agios Pharmaceuticals To Webcast Conference Call Discussing Fourth Quarter And Full Year 2013 Financial Results On March 6, 2014 2/28/2014 7:21:15 AM    More...
Agios Pharmaceuticals Exercises Option To U.S. Development And Commercialization Rights For IDH1 Program Under Celgene (CELG) Collaboration 2/3/2014 9:05:14 AM    More...
Agios Pharmaceuticals Added To NASDAQ Biotechnology Index 12/23/2013 9:28:52 AM    More...
Agios Pharmaceuticals Advances Cancer Metabolism Collaboration With Celgene (CELG) 12/11/2013 9:13:33 AM    More...
1234567